VENICE, FL--(MARKET WIRE)--Aug 22, 2008 -- SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) -- Following are the advances towards effectively managing MRSA "Super-Bug," utilizing already available products from SinoFresh® HealthCare, Inc.

Announcements:

-- SinoFresh Elaborates on New Study Designed to Demonstrate Nasal Spray Formulation Efficacy in Decolonization of MRSA "Super-Bug" in the Nasal Passage

Last update: 10:31 a.m. EDT July 15, 2008

On the heels of the recent announcement stating a commitment to develop a product to attack MRSA -- the so-called "Super-Bug," SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) announced today the continuation of a series of development activities to implement that commitment. This is a study, which will be in the lab phase by the end of July 2008, and according to Dr. John Todhunter, an outside consultant to SinoFresh, "is expected to give robust proof of concept for the nasal formulation designed to kill MRSA hiding in the nose."

-- SinoFresh Announces "Next Step" in Program to Attack "Super-Bug" MRSA

Last update: 12:49 p.m. EDT July 1, 2008

SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News), the makers of SinoFresh Nasal Spray, announced today the next step in a research and development program expected to lead to a nasal spray product for attacking MRSA -- the so-called "Super-Bug" -- reservoirs in the nasal passage. These nasal reservoirs are believed by public health experts to be a significant source of MRSA infections. "This continuation of an earlier study is a concrete expression of SinoFresh's commitment to exploring ways to protect and promote nasal and upper respiratory health and hygiene," according to Charles Fust, CEO of SinoFresh. In July 2005, SinoFresh announced it had achieved positive results in an in vitro study conducted at the Public Health Research Institute under the direction of Dr. Barry Kreiswirth who is the director of the institute's Tuberculosis Center and Hospital Infections Program.

-- SinoFresh® Nasal Spray Kills MRSA "Super-Bug" in Live Noses

-- SinoFresh® Passes First Key Test for Potential to Control "Super-Bug" MRSA

Last update: 12:00 p.m. EDT Aug. 18, 2008

According to William Wilferth, VP for Research and Development at SinoFresh, "These results have exceeded our expectations. The positive results of this in vivo study gives us the solid scientific platform we have needed in order to advance our efforts to fight MRSA to the next level."

SinoFresh® nasal spray attacks MRSA in the nasal passages by destroying the "Super-Bug's" cell walls and membranes by physical means rather than by an antibiotic mechanism involving attack on the metabolism of the microbes as occurs with the use of antibiotics. "Since bacteria can in effect change their metabolism to be resistant to antibiotics, but can't very well change the laws of physics the chances for development of resistance to SinoFresh® Nasal Spray's mode of killing them is much lower," said Dr. Todhunter.

About SinoFresh HealthCare, Inc.

SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) is a developer and marketer of innovative upper respiratory system therapies. The company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms that are suspected to cause pathogenesis of the mouth, nose and throat. The company's lead product, SinoFresh® Nasal and Sinus Care, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The company is also researching how antiseptic cleansing may alleviate chronic sinus distress, a condition that may affect 37 million Americans annually. SinoFresh® products are available in major retail outlets nationwide. More information is available at www.sinofresh.com.

     Contact:
     William Wilferth, R. Ph. M.S.
     VP Research & Development
     SinoFresh HealthCare Inc.
     787 Commerce Drive / Suite 6
     Venice, FL  34292
     Tel: (941) 488-9090
      
     Investor/Public Relations
     Media Contact
     Mica Capital Partners, LLC
     888.522.5613
     Email Contact